The OncoImmunin™ High Throughput Screening (HTS) system is now available for licensing. The system utilizes OncoImmunin's patented cell permeable fluorogenic substrate design for determination of enzymatic activities, including proteases such as caspases-1, 3/7, 6, 8, and 9, beta-secretase, and matrix metalloproteases (MMPs), inside live cells in 96-, 384-, or 1536-well plate formats.

OncoImmunin™ can also design, synthesize, and produce substrates for clients in quantities suitable for HTS for quantitative detection of protease, nuclease, glycosidase, and lipase activities in live cells. Please contact the Company for details regarding these OncoImmunin™ services.

 

.